AR213300A1 - Metanolato cristalino de 7-(d-2-hidroxi-2-fenilacetamido)-3-(1-metil-1h-tetrazol-5-iltrometil)-3-cefem-3-carboxilato de sodio,procedimiento para obtenerlo y procedimiento para convertir dicho metanolato en el anhidrato correspondiente - Google Patents

Metanolato cristalino de 7-(d-2-hidroxi-2-fenilacetamido)-3-(1-metil-1h-tetrazol-5-iltrometil)-3-cefem-3-carboxilato de sodio,procedimiento para obtenerlo y procedimiento para convertir dicho metanolato en el anhidrato correspondiente

Info

Publication number
AR213300A1
AR213300A1 AR265847A AR26584776A AR213300A1 AR 213300 A1 AR213300 A1 AR 213300A1 AR 265847 A AR265847 A AR 265847A AR 26584776 A AR26584776 A AR 26584776A AR 213300 A1 AR213300 A1 AR 213300A1
Authority
AR
Argentina
Prior art keywords
procedure
methanolate
iltrometil
cefem
phenylacetamide
Prior art date
Application number
AR265847A
Other languages
English (en)
Spanish (es)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of AR213300A1 publication Critical patent/AR213300A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AR265847A 1975-12-22 1976-12-14 Metanolato cristalino de 7-(d-2-hidroxi-2-fenilacetamido)-3-(1-metil-1h-tetrazol-5-iltrometil)-3-cefem-3-carboxilato de sodio,procedimiento para obtenerlo y procedimiento para convertir dicho metanolato en el anhidrato correspondiente AR213300A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/642,922 US4054738A (en) 1975-12-22 1975-12-22 Sodium cefamandole crystalline forms

Publications (1)

Publication Number Publication Date
AR213300A1 true AR213300A1 (es) 1979-01-15

Family

ID=24578600

Family Applications (1)

Application Number Title Priority Date Filing Date
AR265847A AR213300A1 (es) 1975-12-22 1976-12-14 Metanolato cristalino de 7-(d-2-hidroxi-2-fenilacetamido)-3-(1-metil-1h-tetrazol-5-iltrometil)-3-cefem-3-carboxilato de sodio,procedimiento para obtenerlo y procedimiento para convertir dicho metanolato en el anhidrato correspondiente

Country Status (31)

Country Link
US (1) US4054738A (ja)
JP (2) JPS5282714A (ja)
AR (1) AR213300A1 (ja)
AT (2) AT348678B (ja)
AU (1) AU505924B2 (ja)
BE (1) BE849415A (ja)
CA (1) CA1080696A (ja)
CH (1) CH628348A5 (ja)
CS (1) CS195746B2 (ja)
DD (1) DD128727A5 (ja)
DE (1) DE2654647C2 (ja)
DK (1) DK153156C (ja)
FI (1) FI66008C (ja)
FR (3) FR2361898A1 (ja)
GB (1) GB1565854A (ja)
GR (1) GR65891B (ja)
HU (1) HU172474B (ja)
IL (3) IL50977A (ja)
LU (1) LU76435A1 (ja)
MX (1) MX3840E (ja)
NL (1) NL187483C (ja)
NO (1) NO148887C (ja)
NZ (1) NZ182694A (ja)
OA (1) OA05518A (ja)
PH (1) PH12191A (ja)
PL (1) PL102739B1 (ja)
PT (1) PT65955B (ja)
RO (3) RO75963A (ja)
SE (3) SE424730B (ja)
SU (3) SU637087A3 (ja)
ZA (1) ZA766957B (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4168376A (en) * 1978-06-05 1979-09-18 Eli Lilly And Company Process for crystalline sodium cefamandole
US4237279A (en) * 1979-07-27 1980-12-02 Eli Lilly And Company Crystalline 3-hydroxycephalosporin solvates
DE3313816A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
DE3313818A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
CA1242699A (en) * 1985-02-01 1988-10-04 Bristol-Myers Company Cefbuperazone and derivatives thereof
JPH0677413B2 (ja) * 1985-05-03 1994-09-28 株式会社フジクラ 高圧直流送電用電力ケーブル
JPS629495U (ja) * 1985-07-01 1987-01-21
GB9717629D0 (en) 1997-08-21 1997-10-22 Johnson Matthey Plc Removal of residual organic solvents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3496171A (en) * 1969-02-17 1970-02-17 Lilly Co Eli Process for improving the physical and chemical properties of cephaloglycin
US3641021A (en) * 1969-04-18 1972-02-08 Lilly Co Eli 3 7-(ring-substituted) cephalosporin compounds
US3692781A (en) * 1971-02-26 1972-09-19 Glaxo Lab Ltd Recovery of pure cephalexin from acidic reaction mixtures
US3819620A (en) * 1972-06-01 1974-06-25 Squibb & Sons Inc 7-(d-alpha-amino-1,4-cyclohexadien-1-ylacet-amido)desacetoxycephalosporanic acid dihydrate
US3862186A (en) * 1972-12-15 1975-01-21 Bristol Myers Co Process for the production of cephalexin monohydrate
US3928592A (en) * 1974-02-22 1975-12-23 Lilly Co Eli Antibiotic pharmaceutical compositions

Also Published As

Publication number Publication date
FR2351985A1 (fr) 1977-12-16
RO75963A (ro) 1981-02-28
FR2351984B1 (ja) 1980-06-27
CA1080696A (en) 1980-07-01
HU172474B (hu) 1978-09-28
FR2361898A1 (fr) 1978-03-17
AU505924B2 (en) 1979-12-06
JPS6183189A (ja) 1986-04-26
AU2001376A (en) 1978-06-01
CS195746B2 (en) 1980-02-29
IL57387A0 (en) 1979-09-30
NO148887C (no) 1984-01-04
MX3840E (es) 1981-08-11
PL102739B1 (pl) 1979-04-30
RO75964A (ro) 1981-02-28
CH628348A5 (de) 1982-02-26
JPS5282714A (en) 1977-07-11
NO148887B (no) 1983-09-26
DE2654647A1 (de) 1977-06-30
RO69709A (ro) 1980-04-15
DK153156B (da) 1988-06-20
US4054738A (en) 1977-10-18
FR2361898B1 (ja) 1980-03-14
FI763682A (ja) 1977-06-23
DK153156C (da) 1989-02-20
FI66008C (fi) 1984-08-10
SU637087A3 (ru) 1978-12-05
NO764222L (ja) 1977-06-23
PT65955B (en) 1978-06-15
JPS61351B2 (ja) 1986-01-08
AT348678B (de) 1979-02-26
DK575576A (da) 1977-06-23
NL7614233A (nl) 1977-06-24
FI66008B (fi) 1984-04-30
IL50977A0 (en) 1977-01-31
SE8201701L (sv) 1982-03-17
ATA948976A (de) 1978-07-15
AT349148B (de) 1979-03-26
GB1565854A (en) 1980-04-23
DE2654647C2 (de) 1982-06-24
SE441096B (sv) 1985-09-09
FR2351985B1 (ja) 1980-06-27
DD128727A5 (de) 1977-12-07
FR2351984A1 (fr) 1977-12-16
ATA217578A (de) 1978-08-15
LU76435A1 (ja) 1977-06-10
PH12191A (en) 1978-11-21
NZ182694A (en) 1978-09-25
NL187483B (nl) 1991-05-16
GR65891B (ja) 1980-12-01
IL57386A0 (en) 1979-09-30
SU671732A3 (ru) 1979-06-30
JPS624393B2 (ja) 1987-01-30
BE849415A (fr) 1977-06-15
IL50977A (en) 1980-02-29
OA05518A (fr) 1981-04-30
SE7614401L (sv) 1977-06-23
ZA766957B (en) 1978-06-28
NL187483C (nl) 1991-10-16
PT65955A (en) 1977-01-01
SE424730B (sv) 1982-08-09
SU1018585A3 (ru) 1983-05-15
SE443564B (sv) 1986-03-03
SE8201702L (sv) 1982-03-17

Similar Documents

Publication Publication Date Title
ES493948A0 (es) Procedimiento para generar halogenos
AR215584A1 (es) Procedimiento para preparar fenilamidinoureas
FR2319742A1 (fr) Structure de joint etanche de dilata
AR211629A1 (es) Procedimiento para limpiar impurezas
MX7282E (es) Procedimiento para mejorar la permeabilidad de las rocas
ES490122A0 (es) Procedimiento para preparar piranonas 5-sustituidas
AR211887A1 (es) Procedimiento para la preparacion de derivados de endolizina
AR213300A1 (es) Metanolato cristalino de 7-(d-2-hidroxi-2-fenilacetamido)-3-(1-metil-1h-tetrazol-5-iltrometil)-3-cefem-3-carboxilato de sodio,procedimiento para obtenerlo y procedimiento para convertir dicho metanolato en el anhidrato correspondiente
AR213831A1 (es) Procedimiento para la preparacion de 11-desoxi-16-aril-omega-tetranorprostaglandina
MX4796E (es) Procedimiento para la preparacion de derivados de 2-iminotiazolina
MX4858E (es) Procedimiento para preparar compuestos de bis-carbamilguanidino-aza-alcano
MX4133E (es) Procedimiento para la preparacion de n-tetrahidrofurfuril-noroximorfonas diastereoisomeras
AR209498A1 (es) Procedimiento para la preparacion de l-piroglutamil-l-pronilamida
AR217664A1 (es) Procedimiento para la preparacion de derivados de oleandomicina
AR215650A1 (es) Procedimiento para preparar 1,3-diaciloxi-2-(2-metil-1,3-benzodioxan-4-on-2-iloxi)-propanos
MX3739E (es) Procedimiento para la preparacion de acilamino-penicilinas-6-substituida
ES496222A0 (es) Procedimiento para mejorar el comportamiento de degradacion de poliesteres aprestados
FI791890A (fi) Blaosanordning med laog bullernivao
MX3846E (es) Procedimiento para la preparacion de 1-hidrocarburo-3 3-difenil-4-hidroximetil-2-pirrolidinonas
AR221240A1 (es) Procedimiento para obtener metanolato cristalino del 7-d-mandelamido-3-(1-metil-1h-tetrazol-5-iltiometil)-3-cefem-4-carboxilato de sodio y el metanolato asi obtenido
FI793613A (fi) Framstaellning av etylenkopolymerer med hoeg densitet i en fluidationsbaeddreaktor
AR213309A1 (es) Procedimiento para preparar 2-amino-isotioureidobencenos substituidos
MX4834E (es) Proceso para la preparacion de 1-benzotiazolil imidazolidinonas
MX4618E (es) Procedimiento para la preparacion de derivados de hidrazinopiridazina
SE7906564L (sv) Tvalkompositioner med forbettrad loslighet